Patent details

EP3155017 Title: IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

Basic Information

Publication number:
EP3155017
PCT Application Number:
US2015033042
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157989567
PCT Publication Number:
WO2015184177
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
French Title of Invention:
PRODUITS PHARMACEUTIQUES PEPTIDIQUES AMÉLIORÉS CONTRE L'INSULINORÉSISTANCE
German Title of Invention:
VERBESSERTE PEPTIDARZNEIMITTEL FÜR INSULINRESISTENZ
SPC Number:

Dates

Filing date:
28/05/2015
Grant date:
10/01/2024
EP Publication Date:
19/04/2017
PCT Publication Date:
03/12/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/01/2024
EP B1 Publication Date:
10/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/05/2024
Expiration date:
28/05/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/01/2024
 
 

Name:
Mederis Diabetes, LLC
Address:
7515 Guinevere Drive, Sugar Land, Texas 77479, United States (US)

Inventor

Name:
NESTOR, John, J.
Address:
United States (US)

Priority

Priority Number:
201462004156 P
Priority Date:
28/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 19/00; C07K 14/605; A61K 38/26; A61K 47/50; A61P 31/10;

Publication

European Patent Bulletin

1

Issue number:
202402
Publication date:
10/01/2024
Description:
Grant (B1)

2

Issue number:
202407
Publication date:
14/02/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages